Keyword: Turku Bioscience Centre

Senior Researcher Pekka Postila from the University of Turku and InFLAMES Flagship has been awarded  €120,000 Investigator Award from the California-based SynGAP Research Fund to investigate the effects of missense mutations on the SynGAP1 protein. Additionally, Doctoral Researcher Aliaa E. Ali has received full two-year PhD funding from the Finnish Cultural Foundation for her work on SynGAP1 modeling.

This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity in 28–29 August 2025, with the title Transforming Drug Development for Tomorrow. Registration is open until Friday, 15 August 2025.

Finnish researchers show in a new study that pituitary macrophages, the immune cells located in the pituitary gland, help regulate hormonal balance. It is possible that in the future, macrophage cells could be used to treat endocrine disorders that can lead, for example, to infertility.

BioCity Turku opens a funding call for researchers belonging to BioCity Turku research programs.

How can sensitive health data be used responsibly in scientific research or how can artificial intelligence help make breakthroughs in medical research? The ECCB2024 conference brings together current themes in computational biology and international researchers in Turku, Finland. 

Registration to BioCity Symposium is open until 16 August 2024. BioCity Symposium is one of the most important meetings in Turku region for researchers working in the fields of bio- and molecular medicine. This year the event is arranged with title Unleashing the Power of Metabolism

Treatment outcomes for breast cancer have become better over the years, but proportion of breast cancers still recur even after long periods without signs of cancer remaining dormant in the body. Finnish cancer researchers discovered a mechanism that wakes up these dormant breast cancer cells and demonstrated that preventing the mechanism can significantly improve treatment outcomes in experimental models.